Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs071240114Recruiting
Randomised, open-label trial in carious lesion comparing Remimazolam with Propofol (2 arms). Primary endpoints: Incidence of hypoxemia and Incidence of hypotension. Started Feb 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs071240114.